Ticagrelor
Ka morao
Ticagrelor ke mohanyetsi oa mocha oa P2Y12 receptor [1].
Ticagrelor e tlalehiloe hore e thibela liphello tsa prothrombotic tsa ADP holim'a platelet ka khahlanong le P2Y12 receptor.Ticagrelor e bontšitse thibelo e feletseng ea platelet aggregation ex vivo.Ho feta moo, Ticagrelor o khothalelitse thibelo e itšetlehileng ka tekanyo ea platelet aggregation ho motho.Ntle le tsena, Ticagrelor e boetse e bontšitse mohanyetsi ea tlamang ka molomo, ka mafolofolo, ka mokhoa o fetohang.Ho fapana le li-inhibitors tse ling, Ticagrelor e boetse e tlalehile ho thibela P2Y12 receptor ntle le phetoho ea metabolism.Ntle ho moo, Ticagrelor ke moemeli oa pele oa thienopyridine anti-platelet mme haholo-holo o sebelisoa ke CYP3A4 le CYP2C19 [1] [2].
Litšupiso:
[1] Zhou D1, Andersson TB, Grimm SW.Tlhahlobo ea in vitro ea litšebelisano tse ka bang teng tsa lithethefatsi tsa lithethefatsi le ticagrelor: cytochrome P450 reaction phenotyping, inhibition, induction, and differential kinetics.Lithethefatsi Metab Dispos.2011 Apr;39(4):703-10.
[2] Li Y1, Landqvist C, Grimm SW.Boitšoaro le metabolism ea ticagrelor, e leng mohanyetsi oa P2Y12 ea receptor, ho litoeba, likhoto le marmosets.Lithethefatsi Metab Dispos.2011 Sep;39(9):1555-67.doi: 10.1124/dmd.111.039669.Epub 2011 Jun 13.
Tlhaloso
Ticagrelor (AZD6140) ke mohanyetsi oa molomo oa P2Y12 o fetolehang bakeng sa phekolo ea platelet aggregation.
Ka Vitro
Ticagrelor e khothalletsa thibelo e kholo ea adenosine 5"- diphosphate (ADP)-e khothalelitse ho lokolloa ha Ca2+ ho li-platelet tsa ished vs bahanyetsi ba bang ba P2Y12R.Phello ena e eketsehileng ea ticagrelor ho feta P2Y12R antagonism ke karolo e itseng e le phello ea ticagrelor e thibelang nucleoside transporter 1 (ENT1) ho li-platelet, e lebisang ho bokelleng ha extracellular adenosine le ts'ebetso ea Gs-coupled adenosine A2A receptors [1].Lisele tsa B16-F10 li bonts'a tšebelisano e fokotsehileng le liplatelete tse tsoang ho litoeba tse tšoaroang ke ticagrelor ha li bapisoa le litoeba tse nang le letsoai [2].
Ka B16-F10 melanoma mehlala ea methapo le methapo ea methapo ea methapo, litoeba tse tšoaroang ka tekanyo ea kliniki ea ticagrelor (10 mg / kg) li bontša ho fokotseha ha matšoafo (84%) le sebete (86%) metastases.Ho feta moo, phekolo ea ticagrelor e ntlafatsa bophelo ha e bapisoa le liphoofolo tse tšoaroang ka letsoai.Phello e tšoanang e bonoa ka mohlala oa kankere ea matsoele ea 4T1, ka ho fokotseha ha matšoafo (55%) le masapo a masapo (87%) metastases ka mor'a phekolo ea ticagrelor [2].Tsamaiso e le 'ngoe ea molomo ea ticagrelor (1-10 mg / kg) e baka phello e thibelang tekanyo e amanang le tekanyo ea platelet aggregation.Ticagrelor, ka tekanyo e phahameng ka ho fetisisa (10 mg / kg) e thibela haholo platelet aggregation ka 1 h ka mor'a dosing 'me tlhōrō ea thibelo e hlokomeloa ka 4 h ka mor'a dosing.
Polokelo
4°C, sireletsa ho tloha leseli, bolokoa tlas'a naetrojene
*Ka solvent : -80°C, likhoeli tse 6;-20°C, khoeli e le 'ngoe (sireletsa leseli, e bolokiloe tlas'a naetrojene)
Sebopeho sa lik'hemik'hale
![2018 GMP-2](http://www.cz-pharma.com/uploads/beaa7119.jpg)
![原料药GMP证书201811(captopril ,thalidomide etc)](http://www.cz-pharma.com/uploads/15b802ef.jpg)
![GMP-of-PMDA-in-Chanyoo-平成28年08月03日 Nantong-Chanyoo-Pharmatech-Co](http://www.cz-pharma.com/uploads/40ac545a.jpg)
![FDA-EIR-Letter-201901](http://www.cz-pharma.com/uploads/FDA-EIR-Letter-201901.jpg)
![Quality management1](http://www.cz-pharma.com/uploads/Quality-management1.png)
Tlhahiso18Merero ea Tlhahlobo ea Boleng e amohetsoeng4, le6merero e tlas'a tumello.
![Quality management2](http://www.cz-pharma.com/uploads/Quality-management2.png)
Sistimi e tsoetseng pele ea boleng ba machaba e thehile motheo o tiileng oa thekiso.
![Quality management3](http://www.cz-pharma.com/uploads/Quality-management3.png)
Tlhokomelo ea boleng e tsamaisana le potoloho eohle ea bophelo ba sehlahisoa ho netefatsa boleng le phello ea kalafo.
![Quality management4](http://www.cz-pharma.com/uploads/Quality-management4.png)
Sehlopha sa Litaba tsa Taolo ea Setsebi se tšehetsa litlhoko tsa boleng nakong ea kopo le ngoliso.
![cpf5](http://www.cz-pharma.com/uploads/cpf5.png)
![cpf6](http://www.cz-pharma.com/uploads/cpf6.png)
Korea Countec Bottled Packaging Line
![cpf7](http://www.cz-pharma.com/uploads/cpf7.png)
![cpf8](http://www.cz-pharma.com/uploads/cpf8.png)
Taiwan CVC Bottled Packaging Line
![cpf9](http://www.cz-pharma.com/uploads/cpf9.png)
![cpf10](http://www.cz-pharma.com/uploads/cpf10.png)
Italy CAM Board Packaging Line
![cpf11](http://www.cz-pharma.com/uploads/cpf11.png)
Mochini oa Sejeremane oa Fette Compacting
![cpf12](http://www.cz-pharma.com/uploads/cpf12.png)
Japan Viswill Tablet Detector
![cpf14-1](http://www.cz-pharma.com/uploads/cpf14-1.png)
Kamore ea ho laola ea DCS
![International cooperation](http://www.cz-pharma.com/uploads/International-cooperation.jpg)
![Domestic cooperation](http://www.cz-pharma.com/uploads/Domestic-cooperation.jpg)